Application 020051

Type
NDA
Sponsor
PHARMACIA AND UPJOHN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GLYNASEGLYBURIDETABLET;ORAL1.5MGYesNo
002GLYNASEGLYBURIDETABLET;ORAL3MGYesNo
003GLYNASEGLYBURIDETABLET;ORAL4.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
004GLYNASEGLYBURIDETABLET;ORAL6MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0009-0341GlynaseglyburidePharmacia and Upjohn Company LLCNDACurrent
0009-0352GlynaseglyburidePharmacia and Upjohn Company LLCNDACurrent
0009-3449GlynaseglyburidePharmacia and Upjohn Company LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
49581SUPPL2017-08-29
49524SUPPL2017-08-24
34214SUPPL2015-05-27
1955SUPPL2015-05-26
34213SUPPL2013-10-22
21081SUPPL2013-10-16
1954SUPPL2011-02-09
34212SUPPL2011-02-07
1953SUPPL2009-11-19
34211SUPPL2009-09-17
34210SUPPL2008-11-07
1952SUPPL2008-11-03
20462SUPPL1997-01-10